04/29/2024 | Press release | Distributed by Public on 04/29/2024 05:03
Filed by the Registrant x
|
|
Filed by a Party other than the Registrant o
|
|
Check the appropriate box:
|
|
o
|
Preliminary Proxy Statement |
o
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
o
|
Definitive Proxy Statement |
x
|
Definitive Additional Materials |
o
|
Soliciting Material under ยง240.14a-12 |
United Therapeutics Corporation | |
(Name of Registrant as Specified In Its Charter)
|
|
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
|
|
Payment of Filing Fee (Check the appropriate box):
|
|
x
|
No fee required. |
o
|
Fee paid previously with preliminary materials. |
o
|
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11. |